Martin Grasse

Martin Grasse has a diverse work experience spanning over multiple companies and roles. Martin is currently the CEO at Gradient Denervation Technologies since March 2022. Prior to this, they worked at Ajax Health as an Operating Partner from October 2021 to March 2022, and as a Principal from April 2019 to October 2021. Martin also served as the Chief Executive Officer at Ablacon, Inc. from May 2021 to October 2021, and as the Chief Operating Officer from April 2019 to May 2021. Before that, they held the position of Senior Director of Business Development at EPIX Therapeutics, Inc. from April 2018 to April 2019. Martin Grasse also worked at Cibiem, Inc. as the Vice President of R&D from January 2017 to April 2018, as the Director of Program Management from March 2014 to January 2017, and as a Marketing Manager from March 2012 to March 2014. Martin gained experience as a Summer Associate at Bain & Company in June 2011 and as an R&D Engineer at BridgePoint Medical, Inc. from December 2009 to August 2010. Furthermore, they worked as a Design Engineer II at St. Jude Medical from February 2008 to December 2009, and as an R&D Intern at St. Jude Medical from May 2007 to August 2007 and from May 2006 to August 2006.

Martin Grasse's education history is as follows:

From 2003 to 2007, Martin attended the University of Wisconsin-Madison, where they obtained a Bachelor of Science (B.S.) degree in Biomedical Engineering. During their time at the university, they also earned a Business Certificate.

In 2006, Martin temporarily studied at the DTU - Technical University of Denmark, focusing on Biomedical Engineering.

Later on, from 2010 to 2012, Martin pursued a Master of Business Administration (MBA) degree at the Harvard Business School.

Additionally, Martin completed another Bachelor of Science (BS) degree in Biomedical Engineering from the University of Wisconsin-Madison, although the exact dates of this degree are not specified.

Overall, Martin Grasse's education is primarily centered around Biomedical Engineering, with later studies focusing on Business through their MBA.